vs
Side-by-side financial comparison of MEDIFAST INC (MED) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $50.3M, roughly 1.5× READING INTERNATIONAL INC). On growth, READING INTERNATIONAL INC posted the faster year-over-year revenue change (-14.2% vs -36.9%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-6.6M). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
MED vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $75.1M | $50.3M |
| Net Profit | — | $-2.6M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | -1.9% |
| Net Margin | — | -5.1% |
| Revenue YoY | -36.9% | -14.2% |
| Net Profit YoY | — | -14.5% |
| EPS (diluted) | $-1.64 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $50.3M | ||
| Q3 25 | $89.4M | $52.2M | ||
| Q2 25 | $105.6M | $60.4M | ||
| Q1 25 | $115.7M | $40.2M | ||
| Q4 24 | $119.0M | $58.6M | ||
| Q3 24 | $140.2M | $60.1M | ||
| Q2 24 | $168.6M | $46.8M | ||
| Q1 24 | $174.7M | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-2.3M | $-4.2M | ||
| Q2 25 | $2.5M | $-2.7M | ||
| Q1 25 | $-772.0K | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $1.1M | $-7.0M | ||
| Q2 24 | $-8.2M | $-12.8M | ||
| Q1 24 | $8.3M | $-13.2M |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | -1.9% | ||
| Q3 25 | -4.6% | -0.6% | ||
| Q2 25 | -1.0% | 4.8% | ||
| Q1 25 | -1.1% | -17.2% | ||
| Q4 24 | 0.6% | 2.6% | ||
| Q3 24 | 1.5% | -0.6% | ||
| Q2 24 | -4.7% | -16.4% | ||
| Q1 24 | 4.5% | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | -2.5% | -8.0% | ||
| Q2 25 | 2.3% | -4.4% | ||
| Q1 25 | -0.7% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | 0.8% | -11.7% | ||
| Q2 24 | -4.8% | -27.4% | ||
| Q1 24 | 4.8% | -29.4% |
| Q4 25 | $-1.64 | $-0.11 | ||
| Q3 25 | $-0.21 | $-0.18 | ||
| Q2 25 | $0.22 | $-0.12 | ||
| Q1 25 | $-0.07 | $-0.21 | ||
| Q4 24 | $0.08 | $-0.11 | ||
| Q3 24 | $0.10 | $-0.31 | ||
| Q2 24 | $-0.75 | $-0.57 | ||
| Q1 24 | $0.76 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $198.9M | $-18.2M |
| Total Assets | $248.0M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $10.5M | ||
| Q3 25 | $173.5M | $8.1M | ||
| Q2 25 | $162.7M | $9.1M | ||
| Q1 25 | $164.6M | $5.9M | ||
| Q4 24 | $162.3M | $12.4M | ||
| Q3 24 | $170.0M | $10.1M | ||
| Q2 24 | $163.5M | $9.3M | ||
| Q1 24 | $156.4M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $198.9M | $-18.2M | ||
| Q3 25 | $214.7M | $-12.1M | ||
| Q2 25 | $216.0M | $-7.7M | ||
| Q1 25 | $211.0M | $-8.1M | ||
| Q4 24 | $210.1M | $-4.4M | ||
| Q3 24 | $207.3M | $1.6M | ||
| Q2 24 | $205.3M | $6.5M | ||
| Q1 24 | $211.0M | $18.0M |
| Q4 25 | $248.0M | $434.9M | ||
| Q3 25 | $268.2M | $435.2M | ||
| Q2 25 | $269.3M | $438.1M | ||
| Q1 25 | $280.0M | $441.0M | ||
| Q4 24 | $284.2M | $471.0M | ||
| Q3 24 | $291.2M | $495.7M | ||
| Q2 24 | $293.5M | $494.9M | ||
| Q1 24 | $302.8M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $4.3M |
| Free Cash FlowOCF − Capex | $-6.6M | $4.1M |
| FCF MarginFCF / Revenue | -8.8% | 8.2% |
| Capex IntensityCapex / Revenue | 1.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $4.3M | ||
| Q3 25 | $12.1M | $295.0K | ||
| Q2 25 | $-3.4M | $1.6M | ||
| Q1 25 | $3.4M | $-7.7M | ||
| Q4 24 | $-4.9M | $8.0M | ||
| Q3 24 | $9.1M | $1.3M | ||
| Q2 24 | $13.1M | $-10.4M | ||
| Q1 24 | $7.3M | $-2.8M |
| Q4 25 | $-6.6M | $4.1M | ||
| Q3 25 | $10.8M | $-246.0K | ||
| Q2 25 | $-4.8M | $1.2M | ||
| Q1 25 | $1.9M | $-8.0M | ||
| Q4 24 | $-7.2M | $7.0M | ||
| Q3 24 | $7.7M | $-1.1M | ||
| Q2 24 | $11.1M | $-10.6M | ||
| Q1 24 | $5.4M | $-4.7M |
| Q4 25 | -8.8% | 8.2% | ||
| Q3 25 | 12.0% | -0.5% | ||
| Q2 25 | -4.5% | 1.9% | ||
| Q1 25 | 1.6% | -19.8% | ||
| Q4 24 | -6.1% | 12.0% | ||
| Q3 24 | 5.5% | -1.8% | ||
| Q2 24 | 6.6% | -22.7% | ||
| Q1 24 | 3.1% | -10.4% |
| Q4 25 | 1.8% | 0.3% | ||
| Q3 25 | 1.5% | 1.0% | ||
| Q2 25 | 1.3% | 0.6% | ||
| Q1 25 | 1.3% | 0.6% | ||
| Q4 24 | 1.9% | 1.7% | ||
| Q3 24 | 1.0% | 4.0% | ||
| Q2 24 | 1.1% | 0.5% | ||
| Q1 24 | 1.1% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |